TOP TIERMARKET NEWSWIRE
SEC Form 4 history

JOHNSON & JOHNSON (JNJ) insider trades

JOHNSON & JOHNSON (JNJ) insider trading activity (SEC Form 4). Over the trailing 90 days, JNJ insiders filed 0 purchases totalling $0 and 6 sales totalling $67.8M — net SELLING of $67.8M. Most recent filing: Sep 4, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
6
$67.8M
Net (90d)
-$67.8M
net selling
Most recent
Sep 4, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 4, 2026Schmid TimothyEVP, WW Chair, MedTechS SaleOE—$274.74$9.2Mfiling
Aug 18, 2026Taubert Jennifer LEVP, WWC. Innovative MedicineS SaleOE—$263.36$4.0Mfiling
Aug 14, 2026Duato JoaquinCEO, COBS SaleOE—$261.17$32.2Mfiling
Aug 7, 2026Forminard ElizabethEVP, GCS SaleOE—$257.00$4.1Mfiling
Aug 7, 2026Duato JoaquinCEO, COBS Sale—$258.15$12.5Mfiling
Jul 21, 2026Broadhurst VanessaEVP, Global Corp AffairsS SaleOE—$251.27$5.8Mfiling
Jun 12, 2026Wengel Kathryn EEVP, Chief TO, Risk OfficerS SaleOE—$241.15$2.4Mfiling